Pharma News, 2019

Another collaborative project from a nanoparticles expert at The University of Texas at Arlington has yielded promising results in the search for more effective, targeted cancer treatments.

PNAS publishes Rutgers New Jersey Medical school study.

SOUTH SAN FRANCISCO, Calif.

JERUSALEM, Sept.

FDA Singles Out 9 More Drug Substances Not for CompoundingFollowing a court win late last month to keep one such drug substance out of the hands of compounders, the US Food and Drug Administration ...

DUBLIN - Allergan plc (NYSE.

Chronic cocaine use could alter genes in your brain and contribute to addiction, a new study finds.

A blood test for signs of inflammation in young people may predict their risks of heart disease and an early death, a new study suggests.

The U.

The two pharma companies have agreed to pay $15 million to certain Ohio counties before an opioid abuse trial to be held in October.

Mylan NV’s generic version Eli Lilly and Co’s lung cancer drug, Alimta, has been given tentative approval by the FDA.

The international team of scientists from Gero Discovery LLC, the Institute of Biomedical Research of Salamanca, and Nanosyn, Inc.